As the only medical association that convenes 190+ state and specialty medical societies and other critical stakeholders, the AMA represents physicians with a unified voice to all key players in health care. For quick reference, the new category I CPT codes and long descriptors are: 87636 Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus types A and B, multiplex amplified probe technique, 87637 Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), influenza virus types A and B, and respiratory syncytial virus, multiplex amplified probe technique. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL CONTAINED ON THIS PAGE. 2016;54(11):2763-2766. 323 0 obj <> endobj that coverage is not influenced by Bill Type and the article should be assumed to Billing and Coding articles provide guidance for the related Local Coverage Determination (LCD) and assist providers in submitting correct claims for payment. our vaccine rep inform us to code 87804 and 87804(-91) because we are billing for both A and B. we just started to bill this, not sure of reimbursement yet. CHICAGO The American Medical Association (AMA) today published an update to the Current Procedural Terminology (CPT) code set that includes new code additions and editorial revisions for reporting medical services sparked by the public health response to the COVID-19 pandemic. presented in the material do not necessarily represent the views of the AHA. No fee schedules, basic unit, relative values or related listings are included in CPT. Instructions for enabling "JavaScript" can be found here. The Centers for Medicare & Medicaid Services (CMS), the federal agency responsible for administration of the Medicare, The AMA leverages its strength by removing the obstacles that interfere with patient care, leading the charge to prevent chronic disease and confront public health crises and, driving the future of medicine to tackle the biggest challenges in health care. Shell vials or equivalent multiwell plate cell culture; identification (additional CPT codes/charges will apply) if culture results warrant. Copyright © 2022, the American Hospital Association, Chicago, Illinois. Information for Clinicians on Rapid Diagnostic Testing for Influenza. article does not apply to that Bill Type. U0005 will be added at an additional charge consistent with applicable payer requirements), 87804 (x2), 8467. . Medicaid and the State Children's Health Insurance Programs, contracts with certain organizations to assist in the administration Current Dental Terminology © 2022 American Dental Association. that coverage is not influenced by Revenue Code and the article should be assumed to apply equally to all Revenue Codes. Applicable FARS/HHSARS apply. Complete absence of all Bill Types indicates Follow manufacturers instructions, including handling of respiratory specimens, as described in the device package insert. #7. The AMA does not directly or indirectly practice medicine or dispense medical services. You acknowledge that the ADA holds all copyright, trademark and other rights in CDT. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not Color-coded control swab packaging for easy positive/negative . opportunity for Oseltamivir (Tamiflu) treatment for positive patients, Results available in approximately 2-4 hours, Article - Billing and Coding: Influenza Diagnostic Tests (A59055). No portion of the American Hospital Association (AHA) copyrighted materials contained within this publication may be All Rights Reserved. without the written consent of the AHA. CMS believes that the Internet is not endorsed by the AHA or any of its affiliates. This revision is due to the 2022 Annual CPT/HCPCS Code Update and is effective on 1/1/2022. ICD-10-CM Codes that Support Medical Necessity, ICD-10-CM Codes that DO NOT Support Medical Necessity, Information for Clinicians on Rapid Diagnostic Testing for Influenza, VIRUS ISOLATION; TISSUE CULTURE INOCULATION, OBSERVATION, AND PRESUMPTIVE IDENTIFICATION BY CYTOPATHIC EFFECT, VIRUS ISOLATION; TISSUE CULTURE, ADDITIONAL STUDIES OR DEFINITIVE IDENTIFICATION (EG, HEMABSORPTION, NEUTRALIZATION, IMMUNOFLUORESCENCE STAIN), EACH ISOLATE, VIRUS ISOLATION; CENTRIFUGE ENHANCED (SHELL VIAL) TECHNIQUE, INCLUDES IDENTIFICATION WITH IMMUNOFLUORESCENCE STAIN, EACH VIRUS, INFECTIOUS AGENT ANTIGEN DETECTION BY IMMUNOFLUORESCENT TECHNIQUE; INFLUENZA B VIRUS, INFECTIOUS AGENT ANTIGEN DETECTION BY IMMUNOFLUORESCENT TECHNIQUE; INFLUENZA A VIRUS, INFECTIOUS AGENT ANTIGEN DETECTION BY IMMUNOASSAY TECHNIQUE (EG, ENZYME IMMUNOASSAY [EIA], ENZYME-LINKED IMMUNOSORBENT ASSAY [ELISA], FLUORESCENCE IMMUNOASSAY [FIA], IMMUNOCHEMILUMINOMETRIC ASSAY [IMCA]), QUALITATIVE OR SEMIQUANTITATIVE; INFLUENZA, A OR B, EACH, INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); INFLUENZA VIRUS, INCLUDES REVERSE TRANSCRIPTION, WHEN PERFORMED, AND AMPLIFIED PROBE TECHNIQUE, EACH TYPE OR SUBTYPE, INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); INFLUENZA VIRUS, FOR MULTIPLE TYPES OR SUB-TYPES, INCLUDES MULTIPLEX REVERSE TRANSCRIPTION, WHEN PERFORMED, AND MULTIPLEX AMPLIFIED PROBE TECHNIQUE, FIRST 2 TYPES OR SUB-TYPES, INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); INFLUENZA VIRUS, FOR MULTIPLE TYPES OR SUB-TYPES, INCLUDES MULTIPLEX REVERSE TRANSCRIPTION, WHEN PERFORMED, AND MULTIPLEX AMPLIFIED PROBE TECHNIQUE, EACH ADDITIONAL INFLUENZA VIRUS TYPE OR SUB-TYPE BEYOND 2 (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE), INFECTIOUS AGENT ANTIGEN DETECTION BY IMMUNOASSAY WITH DIRECT OPTICAL (IE, VISUAL) OBSERVATION; INFLUENZA. According to the EUA, it correctly correctly identified 99.3% of negative and 90.1% of positive flu A samples; 99.9% of negative flu B samples; and 100% of negative and 88.3% of positive COVID-19 . Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. Direct comparison of Alere i and cobas Liat influenza A and B tests for rapid detection of influenza virus infection. It is typified by the Quidel's QuickVue Influenza test. Reference: Centers for Disease Control and Prevention. Influenza A Virus, Influenza B Virus: Reflex Test(s) (Influenza A Subtype by Polymerase Chain Reaction (PCR) and Influenza B Subtype by Polymerase Chain Reaction (PCR): results not reported to facility but will be reported to IDPH and CDC.) CPT is a trademark of the American Medical Association (AMA). Changes to the CPT code set are considered through an open editorial process managed by the CPT Editorial Panel that collects broad input from the health care community and beyond to ensure CPT content reflects the coding demands of digital health, precision medicine, augmented intelligence, and other aspects of a modern health care system. CPT codes . Molnlycke Exufiber absorption comparison. Please do not use this feature to contact CMS. The product we use is "Quick Vue Influenza". No fee schedules, basic unit, relative values or related listings are included in CPT. Viral transport medium acceptable for collection of influenza specimens in 1 mL or 3 mL volumes can be used to transport swabs for COVID-19 testing. Some articles contain a large number of codes. Billing and Coding articles typically include CPT/HCPCS procedure codes, ICD-10-CM diagnosis codes, as well as Bill Type, Revenue, and CPT/HCPCS Modifier codes. PPA* (versus an FDA-cleared influenza A and B molecular assay) A: 81.5%, B: 80.9%. $7,252.00 / Case of 12 PK. Throat or nasopharyngeal (NP) swab or wash, sputum, bronchial washings, bronchoalveolar lavage (BAL). MACs are Medicare contractors that develop LCDs and Articles along with processing of Medicare claims. We will specifically apply our methods to evaluate the potential for predicting routes to drug resistance in pathogens. Response to Comment (RTC) articles list issues raised by external stakeholders during the Proposed LCD comment period. copied without the express written consent of the AHA. Harmon MW, Kendal AP. Sign up to get the latest information about your choice of CMS topics in your inbox. Accessed 4/27/21. "JavaScript" disabled. Description. Your first thought is to code this as acute laryngitis, J04.0; however, this code falls in the J00-J06 range titled "Acute upper respiratory infections" and you see no evidence that this is an . Thanks. Veritor System for Rapid Detection of Flu A + B Product Insert, Table 2 (U.S. Sites) The illness classically presents with sudden onset . Some minor issues are listed as follows. preparation of this material, or the analysis of information provided in the material. Learn more about the process with the AMA. In the United States, a number of RIDTs are commercially available. As used herein, "you" and "your" refer to you and any organization on behalf of which you are acting. End User Point and Click Amendment: However, testing is not needed for all outpatients with signs and symptoms consistent with influenza before making antiviral treatment decisions, particularly once influenza activity has been documented in the community. The AMA is a third party beneficiary to this Agreement. GOVERNMENT AND ITS EMPLOYEES ARE NOT LIABLE FOR ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION, PRODUCT, OR PROCESSES You, your employees and agents are authorized to use CPT only as agreed upon with the AMA internally within your organization within the United States for the sole use by yourself, employees and agents. A Draft article will eventually be replaced by a Billing and Coding article once the Proposed LCD is released to a final LCD. Medicare contractors are required to develop and disseminate Articles. of the Medicare program. CMS believes that the Internet is The UW Clinical Virology Laboratory in the Department of Laboratory Medicine and Pathology incorporates the modified FDA approved Panther Fusion Flu A/B/RSV assay for the rapid detection and differentiation of human influenza A/B, and respiratory syncytial virus (RSV) using real-time PCR. You can use the Contents side panel to help navigate the various sections. Nov 4, 2009. COVID-19/Flu A&B Diagnostic Test. Please note that if you choose to continue without enabling "JavaScript" certain functionalities on this website may not be available. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials. Current Dental Terminology © 2022 American Dental Association. For swabs in saline: OP, NP or anterior nasal swabs may be placed in 1 to 3 mL of sterile saline (0.85 to 0.9%) in a sterile screw cap container. Flu A: 87804; Flu B: 87804-59 (modifier used to indicate separate test) Detectable Analytes. Turnaround time is defined as the usual number of days from the date of pickup of a specimen for The revision clarifies the proper reporting for antigen tests that are read by a machine, as compared to those which can be visually interpreted without a machine. CPT code(s): 87635 (HCPCS: U0003. External controls. testing to when the result is released to the ordering provider. When Medicare patients are being tested via rapid testing for influenza the sites are billing 87804 influenza A AND 87804 influenza B. The document is broken into multiple sections. As used herein, "you" and "your" refer to you and any organization on behalf of which you are acting. Please help me in coding this. Sofia 2 with Advance Result Technology (ART) delivers accurate, objective and automated results in as few as three minutes. To submit a comment or question to CMS, please use the Feedback/Ask a Question link available at the bottom If you are experiencing any technical issues related to the search, selecting the 'OK' button to reset the search data should resolve your issues. Neither the United States Government nor its employees represent that use of such information, product, or processes J Clin Microbiol. The American Hospital Association ("the AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. Revenue Codes are equally subject to this coverage determination. This instructional video reviews the items included in the McKesson Consult Flu Test Kit and provides an overview of step-by-step instructions for using this test kit. Consider sending respiratory specimens (from symptomatic patients) for RT-PCR to confirm results of RIDTs, especially in the following situations: When community influenza activity is low and the rapid diagnostic test result is positive. Also, you can decide how often you want to get updates. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA is your steadfast ally from classroom to Match to residency and beyond. endstream endobj startxref The views and/or positions presented in the material do not necessarily represent the views of the AHA. There are multiple ways to create a PDF of a document that you are currently viewing. hb```G@(p+PjHQTWO:-:Tp20Wi! FDA) now requires that all Rapid influenza diagnostic tests (RIDTs) achieve 80% or higher sensitivity compared with RT-PCR. registered for member area and forum access. 5 things you should know. A and B are separate results/separate tests. The LOINC codes are copyright 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Article document IDs begin with the letter "A" (e.g., A12345). influenza B virus Influenza 87276 Infectious agent antigen detection by immunofluorescent technique; influenza A virus Influenza .